Crodoctor Kft.
- Address
- Kossuth Utca 10, 4080 Hajdunanas, Hungary
Crodoctor Kft - Respiratory Medicine Research Center
Crodoctor Kft is a specialized clinical research center focused on advancing treatments for chronic respiratory diseases. The center demonstrates particular expertise in conducting Phase III and long-term extension studies for novel biologic therapies, with emphasis on chronic obstructive pulmonary disease (COPD) and asthma.
- Long-term safety and tolerability studies of investigational biologics in moderate to severe COPD populations
- Clinical evaluation of innovative therapies for high-risk asthma, including exacerbation prevention trials
- Advanced imaging studies investigating airway inflammation and mucus plugging using high-resolution CT in respiratory disease
The center has established capabilities in assessing airway inflammation biomarkers and conducting complex respiratory clinical trials involving participants across a wide age range. With experience in evaluating cutting-edge monoclonal antibody therapies such as itepekimab, dupilumab, and lunsekimig, Crodoctor Kft contributes to the development of targeted biologic treatments that address underlying inflammatory mechanisms in chronic respiratory tract diseases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Crodoctor Kft.
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of SAR443765 in Adults with High-Risk Asthma Ineligible for Biologic Therapy: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial | Sanofi-Aventis Recherche & Developpement | Phase II | Not Recruiting | May 2025 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| LUNSEKIMIG | 2 | Unknown | 2025-05-13 | 2026-07-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.